Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Sarcoma × fluoroazomycin arabinoside × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hypoxia 3 Uterine Cervical Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1

Interventions

Ifosfamide 7 Doxorubicin 7 Blood Specimen Collection 7 Radiosurgery 6 Surveys and Questionnaires 4 Standard of Care 4 Radiotherapy 4 Proton Therapy 4 X-Rays 3 Vincristine 3 Surgical Procedures, Operative 3 Radiation Dose Hypofractionation 3 Methods 3 Mesna 3 Magnetic Resonance Spectroscopy 3 pegfilgrastim 2 pazopanib 2 dexamethasone acetate 2 Trastuzumab 2 Transurethral Resection of Bladder 2 Restraint, Physical 2 Radiotherapy, Intensity-Modulated 2 Practice Guidelines as Topic 2 Palliative Care 2 Melphalan 2 Heavy Ion Radiotherapy 2 Gene Expression Profiling 2 Exercise 2 Etoposide 2 Enhanced Recovery After Surgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting

Hypoxia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡